Schwab, R. D., Bagley, S., Binder, Z., Lustig, R., O’Rourke, D., Brem, S., . . . Nasrallah, M. (2018, June). 2137 Percentage of viable tumor Versus radiation treatment effect in surgical specimens is not associated with outcomes in recurrent glioblastoma. Journal of Clinical and Translational Science.
Chicago Style (17th ed.) CitationSchwab, Robert D., Stephen Bagley, Zev Binder, Robert Lustig, Donald O’Rourke, Steven Brem, Arati S. Desai, and MacLean Nasrallah. "2137 Percentage of Viable Tumor Versus Radiation Treatment Effect in Surgical Specimens Is Not Associated with Outcomes in Recurrent Glioblastoma." Journal of Clinical and Translational Science Jun. 2018.
MLA (9th ed.) CitationSchwab, Robert D., et al. "2137 Percentage of Viable Tumor Versus Radiation Treatment Effect in Surgical Specimens Is Not Associated with Outcomes in Recurrent Glioblastoma." Journal of Clinical and Translational Science, Jun. 2018.
